Details
| Titel in Übersetzung | Costs of Crohn’s Disease in Germany from the Perspective of the Statutory Health Insurance |
|---|---|
| Originalsprache | Mehrere Sprachen |
| Seiten (von - bis) | 659-666 |
| Seitenumfang | 8 |
| Fachzeitschrift | Zeitschrift fur Gastroenterologie |
| Jahrgang | 47 |
| Ausgabenummer | 7 |
| Frühes Online-Datum | 15 Juli 2009 |
| Publikationsstatus | Veröffentlicht - Juli 2009 |
Abstract
Introduction: Data concerning treatment reality in patients with Crohn's disease (CD) are limited in Germany. The aim of this cross-sectional study was to collect resource use data due to CD and quantify these from the perspective of the Statutory Health Insurance in Germany. Methods: Between March 2006 and July 2007 the patients from 24 ambulatory gastroenterological specialist practices and 2 hospitals were enrolled in an internet-based online database. Based on the collected data, the outpatient and inpatient visits, all procedures as well as medication usage were determined and evaluated from the perspective of the Statutory Health Insurance taking also into consideration patient co-payments, company and pharmacy discounts. 2007 was selected as the price year. Results: Data from 511 CD patients were collected, with 37% being male. Patients were on average 41 years old. According to the calculations, an average CD patient in Germany causes costs of 3767.26 € from the perspective of the Statutory Health Insurance. 68.5% are medication costs, 20.5% result from inpatient care. The costs increase with the severity of the disease. Discussion: This is the first study to calculate costs due to CD (3767 €/year) from the perspective of the Statutory Health Insurance in Germany. To illustrate the costs from the societal perspective, indirect costs need to be included in the calculation in future studies.
Schlagwörter
- Cost analysis, Crohn's disease, Inflammatory bowel disease
ASJC Scopus Sachgebiete
- Medizin (insg.)
- Gastroenterologie
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Zeitschrift fur Gastroenterologie, Jahrgang 47, Nr. 7, 07.2009, S. 659-666.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Die direkten Kosten der Versorgung von Patienten mit Morbus Crohn aus der Perspektive der Gesetzlichen Krankenversicherung
AU - Prenzler, A.
AU - Mittendorf, T.
AU - Conrad, S.
AU - Von Der Schulenburg, J. M.
AU - Bokemeyer, B.
PY - 2009/7
Y1 - 2009/7
N2 - Introduction: Data concerning treatment reality in patients with Crohn's disease (CD) are limited in Germany. The aim of this cross-sectional study was to collect resource use data due to CD and quantify these from the perspective of the Statutory Health Insurance in Germany. Methods: Between March 2006 and July 2007 the patients from 24 ambulatory gastroenterological specialist practices and 2 hospitals were enrolled in an internet-based online database. Based on the collected data, the outpatient and inpatient visits, all procedures as well as medication usage were determined and evaluated from the perspective of the Statutory Health Insurance taking also into consideration patient co-payments, company and pharmacy discounts. 2007 was selected as the price year. Results: Data from 511 CD patients were collected, with 37% being male. Patients were on average 41 years old. According to the calculations, an average CD patient in Germany causes costs of 3767.26 € from the perspective of the Statutory Health Insurance. 68.5% are medication costs, 20.5% result from inpatient care. The costs increase with the severity of the disease. Discussion: This is the first study to calculate costs due to CD (3767 €/year) from the perspective of the Statutory Health Insurance in Germany. To illustrate the costs from the societal perspective, indirect costs need to be included in the calculation in future studies.
AB - Introduction: Data concerning treatment reality in patients with Crohn's disease (CD) are limited in Germany. The aim of this cross-sectional study was to collect resource use data due to CD and quantify these from the perspective of the Statutory Health Insurance in Germany. Methods: Between March 2006 and July 2007 the patients from 24 ambulatory gastroenterological specialist practices and 2 hospitals were enrolled in an internet-based online database. Based on the collected data, the outpatient and inpatient visits, all procedures as well as medication usage were determined and evaluated from the perspective of the Statutory Health Insurance taking also into consideration patient co-payments, company and pharmacy discounts. 2007 was selected as the price year. Results: Data from 511 CD patients were collected, with 37% being male. Patients were on average 41 years old. According to the calculations, an average CD patient in Germany causes costs of 3767.26 € from the perspective of the Statutory Health Insurance. 68.5% are medication costs, 20.5% result from inpatient care. The costs increase with the severity of the disease. Discussion: This is the first study to calculate costs due to CD (3767 €/year) from the perspective of the Statutory Health Insurance in Germany. To illustrate the costs from the societal perspective, indirect costs need to be included in the calculation in future studies.
KW - Cost analysis
KW - Crohn's disease
KW - Inflammatory bowel disease
UR - http://www.scopus.com/inward/record.url?scp=69549088053&partnerID=8YFLogxK
U2 - 10.1055/s-0028-1109059
DO - 10.1055/s-0028-1109059
M3 - Article
C2 - 19606408
AN - SCOPUS:69549088053
VL - 47
SP - 659
EP - 666
JO - Zeitschrift fur Gastroenterologie
JF - Zeitschrift fur Gastroenterologie
SN - 0044-2771
IS - 7
ER -